More drugs, less drink

14 June 2007 By John Foley

The pharma giant could get £7bn from selling its toothpaste and beverage business. Making sugary drinks alongside diet pills makes no sense. Doing so would also also please shareholders, who are nursing heavy losses from fears over Glaxo s diabetes drug, Avandia. A sale would also please shareholders, who are nursing heavy losses from fears over Glaxo s diabetes drug, Avandia.

This content is for Subscribers only

To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)